CAMH will study PEX010, Filament’s botanical psilocybin drug candidate, in a Health Canada-approved clinical trial for mild cognitive impairment VANCOUVER, BC, Feb. 14, 2023 /CNW/ – Filament Health Corp. (OTCQB:...
It looks like a pill, and it tastes just like one…but this isn’t your typical over-the-counter medication. Leading the charge in natural drug development, Vancouver-basedFilament Healthis...
The Case for Microdosing: Why Legalization Matters In a recent episode of the Third Wave Podcast, Vicente LLP founding partner Josh Kappel joined Ali Schaper, CEO and co-founder of...
The Therapeutic Goods Administration (TGA) has announced that Psilocybin and MDMA will be able to be prescribed by specially qualified psychiatrists for the treatment of particular...
In a decision released on 3 February 2023, the Australian Therapeutic Goods Administration (TGA) have agreed to amend the Poisons Standard to include new Schedule 8...
Don’t miss out – Get your tickets early! Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health...
This is what Matt says about himself on Linked In Broad experience with business law, startups, state & federal regulatory compliance, tech transactions, data privacy &...
Greetings, Are you planning to apply for a psilocybin facilitator, service center, manufacturer, or testing lab license in Oregon? Did you know that required operational forms...
Below, we explore a number of research themes that proved salient in 2022. It’s quite a long webpage, so you might prefer to use the contents...
They write One morning, a plain brown box arrived on my doorstep. According to the sender, the contents inside should be handled carefully, because they could...
